oxprenolol has been researched along with bendroflumethiazide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J | 1 |
Freis, ED | 1 |
Barritt, DW; Kettle, MA; Marshall, AJ | 1 |
3 trial(s) available for oxprenolol and bendroflumethiazide
Article | Year |
---|---|
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prazosin; Propranolol; Quinazolines | 1977 |
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Oxprenolol; Propanolamines; Propranolol; Random Allocation; Renin; United States; United States Department of Veterans Affairs | 1984 |
Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Topics: Bendroflumethiazide; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indoles; Indoramin; Male; Oxprenolol; Sleep Wake Disorders | 1980 |
1 other study(ies) available for oxprenolol and bendroflumethiazide
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |